Brief: Context Therapeutics Highlights 2023 Corporate Priorities And Pipeline Milestones

Context Therapeutics

04/01/2023 12:35

Jan 4 (Reuters) - Context Therapeutics Inc  CNTX.O :
    * CONTEXT THERAPEUTICS® HIGHLIGHTS 2023 CORPORATE PRIORITIES
AND
PIPELINE MILESTONES
    * CONTEXT THERAPEUTICS - ELONA BREAST CANCER TRIAL OPEN AND
ENROLLED FIRST PATIENT
    * CONTEXT THERAPEUTICS - ENCOURAGING ENDOMETRIAL AND BREAST
CANCER
DATA IN ONGOING ONA-XR PHASE 2 TRIALS, WITH ADDITIONAL DATA
UPDATES EXPECTED IN 2023
    * CONTEXT THERAPEUTICS - COMPANY EXPECTS ITS CURRENT LEVEL
OF CASH
AND CASH EQUIVALENTS WILL ENABLE COMPANY TO FUND ITS OPERATIONS
INTO Q1 2024

Source text for Eikon:  ID:nGNX9ZCVmH 
Further company coverage:  CNTX.O 
 ((Reuters.Briefs@thomsonreuters.com;))